ArticleEmerging microbes & infections2024

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.

Jing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.